Volume 73, Issue 7 (October 2015)                   Tehran Univ Med J 2015, 73(7): 485-490 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Homaee F, Hasanzadeh Mofrad M, Mirtaymoore M, Afzal Aghaee M, Eslame B. Clinicopathologic aspects and treatment results in malignant sex cord-stromal tumor of ovary. Tehran Univ Med J. 2015; 73 (7) :485-490
URL: http://tumj.tums.ac.ir/article-1-6909-en.html
1- Department of Oncology Radiotherapy, Mashhad University of Medical Sciences, Mashhad, Iran.
2- Department of Gynecology Oncology, Mashhad University of Medical Sciences, Mashhad, Iran. , hasanzademofradm@mums.ac.ir
3- Department of Gynecology Oncology, Mashhad University of Medical Sciences, Mashhad, Iran.
4- Medico-social Unit, Mashhad University of Medical Sciences, Mashhad, Iran.
5- General Physician, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:   (5489 Views)

Background: Ovarian sex cord-stromal tumors (SCST) account for rare ovarian malignancy. These tumors are 5-8% of all ovarian neoplasms. The most common type of sex cord ovarian tumors is granulosa cell tumor (GCT). In this study our purpose was to have a look at some of clinicopathologic aspects and treatment results of these tumors. Methods: In a retrospective study, all documents of patients with SCST was referred to tumor clinics of Ghaem and Omid Hospitals, from 1998 to 2008. The data of patients were collected and analyzed. Results: In 39 (5.9) of the 398 cases, ovarian malignancies was present in SCST. Eight Patients omitted from the study because there were not enough data for them. The commonest pathology was adult granulosa cell tumor in 25 patients (80.6%). Two patients (8.33%) had juvenile granulosa cell tumor, they were 25 and 38 years old. At time of diagnosis, 27 cases (87.1%) were in early stages (stage I). Mean age of patients was 41 years (range 16-76 years) at time of diagnosis of disease. Surgical staging of cancer was performed in 14 patients (46.7%). We did fertility sparing surgery in 12 patients (40%). Two patients were pregnant after surgery. 17 patients (54.80%) did not receive chemotherapy. Three patients (9.7%) received radiotherapy. Overall survival rates were 95% at both 2 years and 5 years. Longer survival had correlation with early stages of disease (P= 0.002). Age, conservative surgery and chemotherapy had no correlations with survival. Conclusion: The prognosis of SCST is almost good. Most of the patients were diagnosed in early stage of disease. In sex cord ovarian tumor, the only factor that have a full effect on survival, is stage of the disease. If the patients desire to preserve fertility, we can do fertility sparing surgery with minimal effect on survival.

Full-Text [PDF 302 kb]   (1827 Downloads)    
Type of Study: Original Article |

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Tehran University Medical Journal TUMS Publications

Designed & Developed by : Yektaweb